The slip
PARKINSON RECEIPTno. 13551
29 Oct 2026, 00:54 UTCdopamine neurons, braak
predictionLPP in dopamine neurons tracks Braak Lewy-body stage
registereda1b93437c351a924
discovery+0.51 p=0.161 n=9
replication-0.30 p=0.436 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.51, p 0.161)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTd93f396b13fa23d83946be3c…
follows b7440a3226af…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 13551: LPP in dopamine neurons, braak
- power
- full sample +0.02 (p 0.942, n 18), 95% CI -0.45 to +0.48. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.03 (p 0.922, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.04 (p 0.861, n 18). could be the mix.
- skeptic
- leave-one-out range -0.06 to +0.16, sign flips 6; without severely affected donors +0.02 (p 0.942, n 18). fragile.
- cell type
- strongest in astrocytes: -0.63 (p 0.0047, n 18) vs +0.02 in dopamine neurons. proposing astrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for LPP in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up LPP · astrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.02 p 0.929 (needs p < 1.7e-4)